Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

NCT04036448

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Local Institution - S02 Seoul, Seoul Teugbyeolsi, South Korea
  • Hallym University Medical Center Anyang, South Korea
  • Keimyung University Dongsan Hospital Daegu, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
View all 26 locations
View Trial Details
Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

NCT03011034

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Washington University School Of Medicine St Louis, Missouri, United States
  • University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
  • University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • ZNA Stuivenberg Antwerp, Belgium
View all 21 locations
View Trial Details
Completed

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

NCT02396134

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes

NCT01196715

Conditions
Bone Marrow Diseases, Disease Attributes, Disease Progression, +6 more
Locations
  • Birmingham Cancer Research UK Clinical Trial Unit Birmingham, United Kingdom
  • St Bartholomew's Hospital London, United Kingdom
  • CECM Institute of Cancer London, United Kingdom
  • King's College Hospital Haematoloy Laboratory London, United Kingdom
View Trial Details

Related conditions